Gisela Menezes Montgomery, M.D., Ph.D.
Medical Director
Area of Expertise:
- Radiology
- Oncology
- Statistics
- Artificial Intelligence
Education:
M.D., Superior School of Health Sciences and
University of Porto
Ph.D. in Radiology (Breast Imaging), University of Utrecht
Years of Experience: 8+ Years
Location: Boston, MA
How do you see imaging transforming the development of novel therapies?
"I would say radiotheranostics is one of the most exciting and fastest developing medical fields. The utilization of injectable radiopharmaceuticals started in the early 40's, with radioactive iodine being used to treat thyroid cancer metastases. Over the past decade, the fast development of theranostic agents offered us an opportunity to go beyond the one-size-fits all treatment model, introducing new therapeutic choices for patients."
"Some key advances driving precision medicine efforts include new technologies to decode the human genome more accurately and at a faster pace and sample repositories of large trials displaying genetic variations linked to diseases across multiple countries.
In addition, online integration of research and clinical data, direct-to-consumer genetic testing and regulatory initiatives to support precision medicine clinical trials. Last but not least, the willingness of health care institutions and patients to adopt this new idea of personalized therapeutic approach."
"As a radiologist, the scientists involved in imaging development are my favorites. From Roentgen and Marie Curie to Hounsfield and Cormack, to mention some of the main contributors."